OUR PRODUCTS

MOBILE APPS

GENERAL INFO

SLN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Silence Therapeutics (SLN) Earnings Date & Reports

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SLN is expected to report earnings to fall 24.42% to -14 cents per share on November 18

Silence Therapeutics SLN Stock Earnings Reports

Q3'25

Est.

$-0.14

Q2'25

Missed

by $0.06

Q1'25

Beat

by $0.20

Q3'23

Beat

by $0.10

Q2'23

Beat

by $0.05

The last earnings report on August 07 showed earnings per share of -18 cents, missing the estimate of -13 cents. With 92.10K shares outstanding, the current market capitalization sits at 238.77M.

View a ticker or compare two or three

Compare

SLN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For SLN
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SLN showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

72 Hammersmith Road

Phone

+44 2034576900

Employees

109

Web

https://www.silence-therapeutics.com